Login
Home
Charts
Search
Watchlist
Products

Archean Chemical Industries Ltd

ACI·NSE
474.60+2.49%Wed, 23 Sept '26

Archean Chemical Industries Ltd

ACI
NSE
474.60
+2.49%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
5,883Cr
Close
Close Price
476.50
Industry
Industry
Chemicals - Inorganic
PE
Price To Earnings
60.39
PS
Price To Sales
5.27
Revenue
Revenue
1,116Cr
Rev Gr TTM
Revenue Growth TTM
-0.43%
PAT Gr TTM
PAT Growth TTM
-39.27%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
290413284213240242346292233255301327
Growth YoY
Revenue Growth YoY%
-1.013.1-25.8-38.0-17.2-41.321.737.5-3.05.1-12.911.9
Expenses
ExpensesCr
195267197141166162257214171200257260
Operating Profit
Operating ProfitCr
9514587717580887863544467
OPM
OPM%
32.935.330.733.531.133.025.626.726.921.414.520.6
Other Income
Other IncomeCr
1191210-299886756
Interest Expense
Interest ExpenseCr
2222330564105
Depreciation
DepreciationCr
181818191920212324242323
PBT
PBTCr
8713580612366755840331644
Tax
TaxCr
213422167182118119414
PAT
PATCr
6610258451648544029241230
Growth YoY
PAT Growth YoY%
3.83.5-57.8-52.2-76.2-52.9-6.7-10.584.5-49.8-77.3-24.4
NPM
NPM%
22.724.620.321.16.519.715.613.712.49.44.19.3
EPS
EPS
5.48.24.73.61.33.94.33.32.41.91.12.5
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
290413284213240242346292233255301327
Growth YoY
Revenue Growth YoY%
-1.013.1-25.8-38.0-17.2-41.321.737.5-3.05.1-12.911.9
Expenses
ExpensesCr
195267197141166162257214171200257260
Operating Profit
Operating ProfitCr
9514587717580887863544467
OPM
OPM%
32.935.330.733.531.133.025.626.726.921.414.520.6
Other Income
Other IncomeCr
1191210-299886756
Interest Expense
Interest ExpenseCr
2222330564105
Depreciation
DepreciationCr
181818191920212324242323
PBT
PBTCr
8713580612366755840331644
Tax
TaxCr
213422167182118119414
PAT
PATCr
6610258451648544029241230
Growth YoY
PAT Growth YoY%
3.83.5-57.8-52.2-76.2-52.9-6.7-10.584.5-49.8-77.3-24.4
NPM
NPM%
22.724.620.321.16.519.715.613.712.49.44.19.3
EPS
EPS
5.48.24.73.61.33.94.33.32.41.91.12.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5666081,1301,4411,3301,0411,0811,116
Growth
Revenue Growth%
7.527.5-7.7-21.73.9-0.4
Expenses
ExpensesCr
493460663807867727842888
Operating Profit
Operating ProfitCr
73148467634463314239228
OPM
OPM%
12.824.341.344.034.830.222.120.4
Other Income
Other IncomeCr
1229124343-32724
Interest Expense
Interest ExpenseCr
11812216297882626
Depreciation
DepreciationCr
4952676970799393
PBT
PBTCr
27-17251512427224147133
Tax
TaxCr
-132063129108624238
PAT
PATCr
40-3618838331916210596
Growth
PAT Growth%
-190.7103.3-16.6-49.2-35.0-39.3
NPM
NPM%
7.1-6.016.626.624.015.69.88.6
EPS
EPS
18.234.725.913.18.77.9
Financial YearMar 2019Mar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5666081,1301,4411,3301,0411,0811,116
Growth
Revenue Growth%
7.527.5-7.7-21.73.9-0.4
Expenses
ExpensesCr
493460663807867727842888
Operating Profit
Operating ProfitCr
73148467634463314239228
OPM
OPM%
12.824.341.344.034.830.222.120.4
Other Income
Other IncomeCr
1229124343-32724
Interest Expense
Interest ExpenseCr
11812216297882626
Depreciation
DepreciationCr
4952676970799393
PBT
PBTCr
27-17251512427224147133
Tax
TaxCr
-132063129108624238
PAT
PATCr
40-3618838331916210596
Growth
PAT Growth%
-190.7103.3-16.6-49.2-35.0-39.3
NPM
NPM%
7.1-6.016.626.624.015.69.88.6
EPS
EPS
18.234.725.913.18.77.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1925252525
Reserves
ReservesCr
2381,4061,6771,8391,910
Current Liabilities
Current LiabilitiesCr
176172135197438
Non Current Liabilities
Non Current LiabilitiesCr
1,093152219332293
Total Liabilities
Total LiabilitiesCr
1,5311,7552,0562,3932,665
Current Assets
Current AssetsCr
399577726691531
Non Current Assets
Non Current AssetsCr
1,1331,1791,3301,7022,133
Total Assets
Total AssetsCr
1,5311,7552,0562,3932,665
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1925252525
Reserves
ReservesCr
2381,4061,6771,8391,910
Current Liabilities
Current LiabilitiesCr
176172135197438
Non Current Liabilities
Non Current LiabilitiesCr
1,093152219332293
Total Liabilities
Total LiabilitiesCr
1,5311,7552,0562,3932,665
Current Assets
Current AssetsCr
399577726691531
Non Current Assets
Non Current AssetsCr
1,1331,1791,3301,7022,133
Total Assets
Total AssetsCr
1,5311,7552,0562,3932,665

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
316148315496379176140
Investing Cash Flow
Investing Cash FlowCr
-25-197-110-290-307-246-293
Financing Cash Flow
Financing Cash FlowCr
-25626-224-212-3365154
Net Cash Flow
Net Cash FlowCr
35-23-19-640-51
Free Cash Flow
Free Cash FlowCr
218397249-81-242
CFO To PAT
CFO To PAT%
791.1-407.1167.1129.7118.9108.7132.5
CFO To EBITDA
CFO To EBITDA%
435.099.767.378.382.056.158.5
Financial YearMar 2019Mar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
316148315496379176140
Investing Cash Flow
Investing Cash FlowCr
-25-197-110-290-307-246-293
Financing Cash Flow
Financing Cash FlowCr
-25626-224-212-3365154
Net Cash Flow
Net Cash FlowCr
35-23-19-640-51
Free Cash Flow
Free Cash FlowCr
218397249-81-242
CFO To PAT
CFO To PAT%
791.1-407.1167.1129.7118.9108.7132.5
CFO To EBITDA
CFO To EBITDA%
435.099.767.378.382.056.158.5

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8,0078,2696,3627,2445,883
Price To Earnings
Price To Earnings
20.925.939.267.860.4
Price To Sales
Price To Sales
5.66.26.16.75.3
Price To Book
Price To Book
5.64.93.43.73.0
EV To EBITDA
EV To EBITDA
12.718.020.832.126.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
79.984.378.483.676.376.3
OPM
OPM%
12.824.341.344.034.830.222.120.4
NPM
NPM%
7.1-6.016.626.624.015.69.88.6
ROCE
ROCE%
35.740.624.211.17.27.2
ROE
ROE%
73.026.718.88.75.55.5
ROA
ROA%
12.321.815.56.84.04.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8,0078,2696,3627,2445,883
Price To Earnings
Price To Earnings
20.925.939.267.860.4
Price To Sales
Price To Sales
5.66.26.16.75.3
Price To Book
Price To Book
5.64.93.43.73.0
EV To EBITDA
EV To EBITDA
12.718.020.832.126.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
79.984.378.483.676.376.3
OPM
OPM%
12.824.341.344.034.830.222.120.4
NPM
NPM%
7.1-6.016.626.624.015.69.88.6
ROCE
ROCE%
35.740.624.211.17.27.2
ROE
ROE%
73.026.718.88.75.55.5
ROA
ROA%
12.321.815.56.84.04.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Archean Chemical Industries is a marine-chemicals company that extracts bromine, industrial salt and sulphate of potash from natural underground brine in the Rann of Kutch, using nothing more than the sun to evaporate and concentrate the brine - a structurally low-cost production method that few producers anywhere can match. Incorporated in 2009 and listed in 2022, the company has grown from a single-site brine processor into India’s largest exporter of both bromine and industrial salt, and it is now using the cash flows from that core operation to build downstream bromine-derivatives plants, acquire an oilfield-chemicals business, and place two strategic bets on the energy transition - silicon-carbide semiconductors and zinc-bromide batteries. The recurring pattern is vertical integration from a captive natural resource: every new engine is designed to consume the output of the one before it, moving further away from commodity pricing and closer to the end customer. # Business segments Five engines at different stages - a marine-chemicals cash cow, two specialty-chemical platforms in ramp-up, and two advanced-materials bets under construction - each built with the cash flows of the one before. ## 1. Marine chemicals: the brine-to-bulk cash engine **Industrial salt and liquid bromine, extracted from captive brine reservoirs by solar evaporation, generate the export revenues that fund everything else - salt alone brings in roughly 70% of sales.** - **Captive brine, not purchased feedstock** - the company draws brine from its own reservoirs in the Great Rann of Kutch, one of the world’s largest salt-marsh ecosystems, and concentrates it in solar evaporation ponds; that is how it achieves a cost position among the lowest globally for bromine and avoids the energy-intensive chemical routes most SOP producers rely on. - **Industrial salt is the volume anchor** - with 7.5 million metric tonnes of annual capacity and purity above 99.5% NaCl, the salt business serves only four or five chlor-alkali customers, all overseas, and the largest - Japanese trading house Sojitz - alone accounts for 60-65% of the segment’s revenue under long-term bilateral contracts. - **Bromine is the specialty lever** - from 42,000 tonnes of annual capacity, the company supplies more than 98% of India’s bromine exports to roughly 43 customers in pharmaceuticals, agrochemicals, flame retardants and water treatment, with a portion of output now reserved as captive feedstock for its own downstream derivatives plant. - **SOP is the fixer-upper** - as India’s only producer of natural sea-brine-based sulphate of potash, the company has 132,000 tonnes of capacity but shipped only 644 tonnes in the last fiscal year while it re-engineers the entire manufacturing process to resolve a salt-contamination problem that had suppressed output for several years. - **The site itself is a moat** - the integrated Hajipir facility sits close to Jakhau Jetty and Mundra Port in Gujarat, runs on hybrid renewable power that has cut coal burn by roughly 1,500 tonnes a month, and operates a zero-liquid-discharge system so no effluent leaves the plant. ## 2. Bromine derivatives: converting captive bromine into higher-margin specialties **A wholly owned subsidiary takes bromine from the parent’s tanks and turns it into clear brine fluids for oil drilling, PTA catalysts for polyester, and flame retardants - same molecule, better price.** - **Fed by the parent’s bromine expansion** - the 14,000 tonnes of bromine capacity added in 2023 was built specifically to supply this plant, so Acume Chemicals buys its key raw material at cost rather than at merchant-market prices, giving it a structural margin advantage over standalone derivative producers. - **Bought, not just built** - the Jhagadia facility in Gujarat was commissioned in March 2024 with 18,000 tonnes of annual capacity across calcium bromide and brominated catalysts, and it is still ramping up, running at about 45% utilisation while customer trials and global approvals progress. - **Early traction in oilfield and battery markets** - one inorganic bromide has already been approved for use in batteries, zinc-bromide volumes are scaling for select customers, and the business has won acceptance at global oil-and-gas and agrochemical multinationals in the Middle East, Africa and India. ## 3. Oilfield chemicals: a distressed-asset revival with five plants **Acquired out of insolvency for ₹77 crore, Idealis Mudchemie gives Archean a ready-made platform in drilling fluids and mud chemicals - a customer overlap with the bromine-derivatives business that lets the group sell a fuller basket to oilfield service companies.** - **Five plants, three already running trials** - the manufacturing footprint spans Gujarat, Andhra Pradesh and Tamil Nadu; three units have been commissioned and are dispatching samples to international customers, while a Gujarat plant awaits state approvals and the Nagri plant’s starch and PAC product roadmap is being redefined. - **A reverse merger to simplify the structure** - the wholly owned subsidiary, Idealis Chemicals Private Limited, is being amalgamated into another wholly owned subsidiary, Idealis Mudchemie Private Limited, leaving Archean with a cleaner chain of control and no change in its own shareholding. ## 4. Silicon-carbide semiconductors: India’s first commercial compound-semiconductor fab **Through step-down subsidiary SiCSem, Archean is building a ₹2,067-crore fabrication and packaging plant in Bhubaneswar that will make silicon-carbide power devices - the chips that go into electric vehicles, fast chargers and renewable-energy systems - with exclusive process technology from its UK partner.** - **Government-backed and the only one of its kind** - the project is approved under the India Semiconductor Mission, a fiscal-support agreement was signed in May 2026, and SiCSem remains the sole compound-semiconductor fab-plus-ATMP project sanctioned under the programme. - **Technology access through ownership** - Archean holds roughly 22% of Clas-SiC Wafer Fab in the UK, a dedicated silicon-carbide foundry, securing exclusive rights to bring its proven fabrication processes to India; a Singapore R&D subsidiary and an on-site lab with IIT Bhubaneswar support the technology pipeline. - **Capacity designed for domestic substitution** - at full Phase 1 output, the plant will process 60,000 wafers a year and package 96 million units annually, targeting a market where India currently imports virtually all of its compound-semiconductor devices. ## 5. Zinc-bromide batteries: a bet on bromine-powered energy storage **Archean is the anchor investor in Offgrid Energy Labs, a US-based startup whose ZincGel flow battery runs on zinc-bromide chemistry - a direct vertical play that turns the company’s captive bromine into the electrolyte for long-duration grid storage.** - **Bromine from the Rann into the battery supply chain** - with a roughly 18-21% stake acquired for about USD 12 million, Archean positions itself as the natural bromine supplier to a technology that uses zinc and bromine as its core materials, sidestepping the lithium, cobalt and nickel supply chains that dominate conventional batteries. - **Designed for stationary storage, not cars** - the ZincGel system claims roughly twice the cycle life of typical lithium-ion, about 90% round-trip efficiency, and the ability to discharge for 6-12 hours without significant degradation, making it suited to solar farms, microgrids and industrial peak-shaving. - **Pilot first, giga-factory later** - a 10 MWh pilot line is being set up in the UK, with the stated intention of building a large-scale manufacturing facility in India, where projected battery-storage demand exceeds 236 GWh by 2032. # Group structure and partners **The listed parent, Archean Chemical, sits above three wholly owned operating platforms and two step-down growth ventures, with strategic equity stakes in a UK semiconductor foundry and a US battery startup tying the new engines back to the core bromine resource.** - **Wholly owned operating subsidiaries** - Acume Chemicals runs the bromine-derivatives plant at Jhagadia; Neun Infra holds the 70% stake in SiCSem and is the vehicle for energy-storage initiatives; Idealis Chemicals is being merged into Idealis Mudchemie. - **Step-down operating entities** - Idealis Mudchemie operates five oilfield-chemical plants; SiCSem is building the Bhubaneswar semiconductor fab; SiCSem Star in Singapore provides R&D and technology support for the SiC project. - **Strategic equity partners** - a 22% stake in Clas-SiC Wafer Fab (UK) secures exclusive SiC process technology for India; an 18-21% stake in Offgrid Energy Labs (US) anchors the zinc-bromide battery play. - **Government and institutional relationships** - the India Semiconductor Mission provides fiscal support for the SiCSem fab; IIT Bhubaneswar is building a ₹65-crore development lab inside the facility; the Gujarat government has signed an MoU for a captive 7-MMTPA salt jetty along the state’s coastline.

Documents — Archean Chemical Industries Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/yhv1tcj6ls3f3j4pd1zrotxs.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/q0q73bry9s2ly3hsjnl5cy6o.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/6p3sx8ptv8acdq29ro6qb8fg.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/kgz60e7pg8730opti7zml567.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/7c7maedixlgbv0cmpts5a0k5.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/fvsjf4uh9r8y52oufemqcs40.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/uh154cpwf46cxa16q1git0zx.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/jspinr7tjp3areix577mrsvq.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/ggy9n6id3zy3p76fq73thfmn.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/5kew5x3ncdz1wy7xct0d1p4l.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/ycohgx55hiaa39qc5hp6657z.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/ptjac5cg45s250h3bju7tyec.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/a01wia6xq7motvkbuaj447xy.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/sej046e3htw0qo5fp3tk6yfa.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/snzo5pryr0euafl41nd6zfpm.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/6pgok9r6b7jgm2b7tleyaryw.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/1s452muaz15263mmaxuo354t.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/mcp3qt7dsvyjc9adl9mezo6i.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/6888hju496bqvyyt32mgwlp3.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/e4ob5dw7iw8eesq4nrg374d6.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/fan8f70fw56m3iw3810lkz93.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/kmo436v1p3dyd2jk3nc3bq7d.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/l47gwnbpe7vfkpah5u30henc.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/bdvvuuduh3q7amvl8rwotbue.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/76vdq30b66c63957l9qcei41.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/91xw1njbxkp28baq322e65uu.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/5a9zsmif7x7c621uwqouy4fv.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/8nlwlmp914hm6k7ma97sngt9.pdf

Concall Transcript Summaries — Archean Chemical Industries Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AACI/transcript-notes/202606/yhv1tcj6ls3f3j4pd1zrotxs.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AACI/transcript-notes/202603/q0q73bry9s2ly3hsjnl5cy6o.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AACI/transcript-notes/202512/6p3sx8ptv8acdq29ro6qb8fg.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AACI/transcript-notes/202509/kgz60e7pg8730opti7zml567.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AACI/transcript-notes/202506/7c7maedixlgbv0cmpts5a0k5.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AACI/transcript-notes/202503/fvsjf4uh9r8y52oufemqcs40.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AACI/transcript-notes/202412/uh154cpwf46cxa16q1git0zx.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AACI/transcript-notes/202409/jspinr7tjp3areix577mrsvq.pdf